Academic Journal

Non-adherence to antihypertensive drugs and its risk factors among hypertensive patients, Marrakech, Morocco.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Non-adherence to antihypertensive drugs and its risk factors among hypertensive patients, Marrakech, Morocco.
Συγγραφείς: Belayachi S; Laboratoire Agroalimentaire et Santé, Faculté des Sciences et Techniques, Hassan First University of Settat, Settat, Morocco., Boukhari FZ; Laboratoire Agroalimentaire et Santé, Faculté des Sciences et Techniques, Hassan First University of Settat, Settat, Morocco., Essayagh F; Laboratoire Droit Privé et Enjeux de Développement, Faculté des Sciences Juridiques, Économiques et Sociales, Université Sidi Mohamed Ben Abdellah, Fès, Morocco., Terkiba O; Laboratoire Sciences et Technologies de la Santé, Institut Supérieur des Sciences de la Santé, Hassan First University of Settat, Settat, Morocco., Zohoun A; Unité D'enseignement et de Recherche en Hématologie, Faculté des Sciences de la Santé, Université d'Abomey-Calavi, Cotonou, Bénin., Essayagh M; Office National de Sécurité Sanitaire des Produits Alimentaires, Oriental, Morocco., Essayagh T; Laboratoire Sciences et Technologies de la Santé, Institut Supérieur des Sciences de la Santé, Hassan First University of Settat, Settat, Morocco., Essayagh S; Laboratoire Agroalimentaire et Santé, Faculté des Sciences et Techniques, Hassan First University of Settat, Settat, Morocco.
Πηγή: PLOS global public health [PLOS Glob Public Health] 2024 Aug 27; Vol. 4 (8), pp. e0002774. Date of Electronic Publication: 2024 Aug 27 (Print Publication: 2024).
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Public Library of Science Country of Publication: United States NLM ID: 9918283779606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-3375 (Electronic) Linking ISSN: 27673375 NLM ISO Abbreviation: PLOS Glob Public Health Subsets: PubMed not MEDLINE
Imprint Name(s): Original Publication: San Francisco, California : Public Library of Science, [2021]-
Περίληψη: Non-adherence to hypertensive drugs is a barrier to controlling blood pressure and decreases hypertensive patients' quality of life. The aim of this study was to determine the prevalence of non-adherence to hypertensive drugs among hypertensive patients treated at Marrakech's primary health care facilities. A cross-sectional survey of 922 hypertensive patients treated at Marrakech's primary health care facilities for arterial hypertension was conducted between 2021 and 2022. For collecting data, two questionnaires were employed. One was administered during an interview to patients and focused on socio-demographic, behavioral, and clinical variables, as well as hypertensive treatment characteristics and the care-patient-physician triad. The physician self-administered the second questionnaire to assess therapeutic inertia. Non-adherence risk factors were identified using multivariate logistic regression. A total of 760 participants did not adhere to the hypertensive drugs, with a prevalence of 82.4%. The average age was 62.8±9.8 years, and 600 (78.9%) of the participants were female. Moderate stress, unsatisfactory family support, uncontrolled hypertension, the presence of depressive symptoms, an insufficient patient-physician interaction, and inadequate medical management of cardiovascular risk factors were associated with drug non-adherence. Non-adherence to hypertensive treatment is common in Marrakech. Regular therapeutic education classes and support group meetings must be scheduled. A performance-based remuneration system to incentivize health-care workers should be investigated.
(Copyright: © 2024 Belayachi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
Competing Interests: The authors have declared that no competing interests exist.
References: Ann Cardiol Angeiol (Paris). 2010 Jun;59(3):131-7. (PMID: 20510914)
Eur J Cardiovasc Nurs. 2021 May 22;20(4):324-330. (PMID: 33620474)
Eur Heart J. 2013 Jul;34(28):2159-219. (PMID: 23771844)
Hypertension. 2022 Jan;79(1):e1-e14. (PMID: 34615363)
PLoS One. 2017 Feb 1;12(2):e0171203. (PMID: 28146584)
Pharmacotherapy. 2006 Apr;26(4):483-92. (PMID: 16553506)
PLoS One. 2019 Aug 9;14(8):e0220710. (PMID: 31398197)
J Gen Intern Med. 2002 Jul;17(7):504-11. (PMID: 12133140)
J Family Med Prim Care. 2019 Mar;8(3):966-971. (PMID: 31041234)
J Clin Hypertens (Greenwich). 2009 Apr;11(4):183-91. (PMID: 19614802)
Health Rep. 2016 Jun 15;27(6):3-8. (PMID: 27305075)
J Gen Intern Med. 2001 Sep;16(9):606-13. (PMID: 11556941)
West Afr J Med. 2020 Oct;37(5):481-489. (PMID: 33058123)
ARYA Atheroscler. 2016 Jul;12(4):166-171. (PMID: 28149311)
Eur J Cardiovasc Nurs. 2013 Feb;12(1):17-24. (PMID: 21704563)
Sci Rep. 2023 Mar 6;13(1):3740. (PMID: 36878989)
Arch Intern Med. 2000 Jul 24;160(14):2101-7. (PMID: 10904452)
Aging Ment Health. 2008 Mar;12(2):183-92. (PMID: 18389398)
PLoS One. 2023 Jan 27;18(1):e0281129. (PMID: 36706106)
Prev Chronic Dis. 2019 Mar 21;16:E32. (PMID: 30900546)
Presse Med. 2001 Jun 16-23;30(21):1044-8. (PMID: 11471275)
Curr Hypertens Rev. 2014;10(1):41-8. (PMID: 25392143)
Biol Psychiatry. 2007 Nov 15;62(10):1183-6. (PMID: 17692829)
Entry Date(s): Date Created: 20240827 Latest Revision: 20240829
Update Code: 20260130
PubMed Central ID: PMC11349104
DOI: 10.1371/journal.pgph.0002774
PMID: 39190663
Βάση Δεδομένων: MEDLINE